Mike Walton

Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone

Paul A. Clarke, Isabelle Hostein, Udai Banerji et al. · Oncogene · 2000 · 199 citations

Signal Transduction, Medicine, Colorectal Cancer +8

A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors

Simon Pacey, Richard H. Wilson, Mike Walton et al. · Clinical Cancer Research · 2011 · 189 citations · Full text

A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma

Simon Pacey, Martin Gore, David Chao et al. · Investigational New Drugs · 2010 · 137 citations

Surgical Oncology, Oncology, Phase Ii Trial +6

Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors

Stuart C. Wilson, Butrus Atrash, Clare Barlow et al. · Bioorganic & Medicinal Chemistry · 2011 · 35 citations · Full text

Combinatorial Chemistry, Cdk Inhibitors, Biochemistry +5

Community Engagement and Data Disclosure in Environmental Health Research

Erin N. Haynes, Sarah Elam, Roxanne Burns et al. · Environmental Health Perspectives · 2016 · 26 citations · Full text

Community Perception, Occupational Health Sciences, Health Studies +23